Want to see ALNY full AI Analyst Report?
Alnylam Pharma (ALNY) Ownership Overview
0.26% Insiders
45.01% Mutual Funds
23.93% Other Institutional Investors
22.67% ETFs
8.13% Public Companies and Individual Investors
The ownership structure of Alnylam Pharma (ALNY) stock is a mix of institutional, retail, and individual investors. Approximately 91.61% of the company’s stock is owned by Institutional Investors, 0.26% is owned by Insiders, and 8.13% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
Apr 07, 2026 | xxxxxxxxxxxxx | $519014 | |
Mar 06, 2026 | xxxxxxxxxxxxx | $745984 | |
Mar 06, 2026 | xxxxxxxxxxxxx | $947581 | |
Mar 06, 2026 | xxxxxxxxxxxxx | $797351 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
Jun 30, 2026 | xxxxxxxxxxxxx | $49228339 | |
Jun 30, 2026 | xxxxxxxxxxxxx | $29977772 | |
Jun 30, 2026 | xxxxxxxxxxxxx | $679124 | |
Jun 30, 2026 | xxxxxxxxxxxxx | $588631955 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 12,409,125 | Institution | 9.27% | 3,085,901,205 | |
| 11,289,843 | Institution | 8.44% | 2,807,558,157 | |
| 8,024,520 | Institution | 6.00% | 1,995,537,634 | |
| 6,554,230 | Institution | 4.90% | 1,629,905,916 | |
| 4,314,775 | Institution | 3.22% | 1,072,998,247 | |
| 3,744,659 | Institution | 2.80% | 931,221,800 | |
| 2,737,573 | Institution | 2.05% | 680,779,654 | |
| 2,533,104 | Institution | 1.89% | 629,932,303 | |
| 2,218,165 | Institution | 1.66% | 551,613,272 | |
| 2,072,864 | Institution | 1.55% | 515,479,820 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 11,289,843 | Institution | 8.44% | 2,807,558,157 | |
| 8,024,520 | Institution | 6.00% | 1,995,537,634 | |
| 3,744,659 | Institution | 2.80% | 931,221,800 | |
| 2,737,573 | Institution | 2.05% | 680,779,654 | |
| 2,533,104 | Institution | 1.89% | 629,932,303 | |
| 2,218,165 | Institution | 1.66% | 551,613,272 | |
| 2,072,864 | Institution | 1.55% | 515,479,820 | |
| 1,947,787 | Institution | 1.46% | 484,375,671 | |
| 1,715,880 | Institution | 1.28% | 426,705,038 | |
| 1,670,679 | Institution | 1.25% | 415,464,454 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 4,252,231 | Institution | 3.18% | 873,918,515 | |
| 2,889,496 | Institution | 2.16% | 593,849,218 | |
| 2,841,775 | Institution | 2.12% | 706,692,607 | |
| 1,612,356 | Institution | 1.20% | 331,371,405 | |
| 1,537,623 | Institution | 1.15% | 316,012,279 | |
| 1,020,994 | Institution | 0.76% | 209,834,687 | |
| 1,016,138 | Institution | 0.76% | 252,693,198 | |
| 791,864 | Institution | 0.59% | 195,994,259 | |
| 763,467 | Institution | 0.57% | 188,965,717 | |
| 751,386 | Institution | 0.56% | 186,854,670 |
FAQ
Who Owns Alnylam Pharmaceuticals (ALNY)?
According to the latest TipRanks data, approximately 23.93% of the company's stock is held by institutional investors, 0.26% is held by insiders, and 8.13% is held by retail investors.
What percentage of Alnylam Pharmaceuticals (ALNY) stock is held by institutional investors?
According to the latest TipRanks data, approximately 23.93% of Alnylam Pharmaceuticals (ALNY) stock is held by institutional investors.
What percentage of Alnylam Pharmaceuticals (ALNY) stock is held by retail investors?
According to the latest TipRanks data, approximately 8.13% of Alnylam Pharmaceuticals (ALNY) stock is held by retail investors.
Who owns the most shares of Alnylam Pharmaceuticals (ALNY)?
Vanguard owns the most shares of Alnylam Pharmaceuticals (ALNY).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.